Alimera Merger: New Board, Stock Cancellation, and CVRs
Company Announcements

Alimera Merger: New Board, Stock Cancellation, and CVRs

The latest announcement is out from Alimera ( (ALIM) ).

In a significant financial move, a company merger led to the cancellation of existing common stock, with shareholders receiving $5.50 per share and a contingent value right (CVR), entitling them to future milestone payments. Stock and option holders experienced various adjustments and conversions based on the merger terms, with specific payouts linked to the achievement of revenue milestones in the coming years. Post-merger, the original company’s board was replaced, and the merged entity delisted from Nasdaq, signaling substantial changes in its corporate structure and stock market presence.

For a thorough assessment of ALIM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyANI Pharmaceuticals completes acquisition of Alimera Sciences
TheFlyANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App